Rusconi S - Search Results

1

Factors involved in continuance of atazanavir-based regimens: Results from a cohort of HIV1-positive patients.

Giacomelli A, Oreni L, Franzetti M, Di Cristo V, Colella E, Ridolfo AL, Galli M, Rusconi S. Giacomelli A, et al. Among authors: rusconi s. Antiviral Res. 2016 May;129:52-57. doi: 10.1016/j.antiviral.2016.02.010. Epub 2016 Feb 20. Antiviral Res. 2016. PMID: 26902109

2

Tracheoesophageal fistula in an HIV-1-positive man due to dual infection of Candida albicans and cytomegalovirus.

Rusconi S, Meroni L, Galli M. Rusconi S, et al. Chest. 1994 Jul;106(1):284-5. doi: 10.1378/chest.106.1.284. Chest. 1994. PMID: 8020287

3

Serum 2'-5'-oligoadenylate synthetase levels and clinical response to interferon-beta therapy in women with genital human papillomavirus infection.

Rusconi S, Agarossi A, Ravasi L, Tonta A, Conti M, Galli M. Rusconi S, et al. J Infect Dis. 1994 May;169(5):1112-5. doi: 10.1093/infdis/169.5.1112. J Infect Dis. 1994. PMID: 8169403

4

No evidence of a higher risk of progression to AIDS in patients with HIV-1-related severe thrombocytopenia.

Galli M, Musicco M, Gervasoni C, Ridolfo AL, Niero F, Rusconi S, Riva A, Voltolin L, Lupo A, Lovicu GF, Radice D, Moroni M. Galli M, et al. Among authors: rusconi s. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jul;12(3):268-75. doi: 10.1097/00042560-199607000-00006. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8673530

5

Human immunodeficiency virus (HIV) phenotype and interleukin-2/ interleukin-10 ratio are associated markers of protection and progression in HIV infection.

Clerici M, Balotta C, Salvaggio A, Riva C, Trabattoni D, Papagno L, Berlusconi A, Rusconi S, Villa ML, Moroni M, Galli M. Clerici M, et al. Among authors: rusconi s. Blood. 1996 Jul 15;88(2):574-9. Blood. 1996. PMID: 8695805 Free article.

6

Still's disease in a patient infected with human immunodeficiency virus type I.

Antinori S, Rusconi S, Ridolfo AL, Orlando G. Antinori S, et al. Among authors: rusconi s. Clin Exp Rheumatol. 1995 Nov-Dec;13(6):759-61. Clin Exp Rheumatol. 1995. PMID: 8835252

7

Patterns of in vitro anti-human immunodeficiency virus type 1 antibody production in long-term nonprogressors.

Rusconi S, Berlusconi A, Papagno L, Colombo MC, De Maddalena C, Riva A, Bagnarelli P, Balotta C, Galli M. Rusconi S, et al. Clin Immunol Immunopathol. 1997 Dec;85(3):320-3. doi: 10.1006/clin.1997.4470. Clin Immunol Immunopathol. 1997. PMID: 9400632 Free article.

8

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection.

d'Arminio Monforte A, Testa L, Adorni F, Chiesa E, Bini T, Moscatelli GC, Abeli C, Rusconi S, Sollima S, Balotta C, Musicco M, Galli M, Moroni M. d'Arminio Monforte A, et al. Among authors: rusconi s. AIDS. 1998 Sep 10;12(13):1631-7. doi: 10.1097/00002030-199813000-00010. AIDS. 1998. PMID: 9764782 Clinical Trial.

9

Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals.

Rusconi S, Santambrogio S, Di Marco A, Colombo MC, Citterio P, Adorni F, Galli M. Rusconi S, et al. AIDS Res Hum Retroviruses. 1998 Oct 10;14(15):1341-3. doi: 10.1089/aid.1998.14.1341. AIDS Res Hum Retroviruses. 1998. PMID: 9788675

10

Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects.

Rusconi S, Bulgheroni E, La Seta Catamancio S, Croce F, Lo Cicero M, Citterio P, Galli M. Rusconi S, et al. J Antimicrob Chemother. 2002 Feb;49(2):427-9. doi: 10.1093/jac/49.2.427. J Antimicrob Chemother. 2002. PMID: 11815597 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

430 results

Search Page

Filters